Antioxidant and Antifibrotic Effect of a Herbal Formulation In Vitro and in the Experimental Andropause via Nrf2HO-1 Signaling Pathway

Abstract EN

The Korean herbal formulation Ojayeonjonghwan is used for improving late-onset hypogonadism (LOH) symptoms such as erectile dysfunction (ED).

A previous research suggested that a modified Ojayeonjonghwan (KH-204) could be used as an alternative to the treatment for ED.

The pharmacological effects were examined in different conditions, including in vitro and in vivo.

We measured the survival rate of TM3 Leydig cells under the oxidative stress condition.

The s.c.

injection of leuprorelin was used to induce androgen deprivation.

We measured serum testosterone levels, oxidative stress, and apoptosis.

The results of the treatment by KH-204 (1) preserved TM3 cells from oxidative stress by improving the expression of nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1); (2) lowered the expression of transforming growth factor-beta (TGF-β) 1/SMAD; (3) increased the average of serum testosterone in androgen-deprived male rats; (4) kept the activation of spermatogenesis; (5) upgraded the contents of 8-hydroxy-20-deoxyguanosine (8-OHdG) and degraded the contents of superoxide dismutase (SOD); and (6) reduced apoptosis.

We studied that KH-204 improved testicular dysfunction in LOH.

It is likely, at least in part, to degrade oxidative stress through the Nrf2/HO-1 pathway.

These findings may offer credible evidences for the use of new alternative therapies to treat LOH.